|
|
|
|
| LEADER |
00000nab a2200000 a 4500 |
| 001 |
vtls000739746 |
| 003 |
SK-MaSNL |
| 005 |
20260304112908.0 |
| 008 |
250429c2000 xo 0 slo |
| 015 |
|
|
|a SNBRB2000/12-35056
|
| 035 |
|
|
|a CLN000091599
|
| 035 |
|
|
|a urn:nbn:sk:snk-abbtvd
|
| 035 |
|
|
|a (urnnbn)urn:nbn:sk:snk:ar-0059kx
|
| 035 |
|
|
|a (uuid)1e24dfc5-e36e-418c-8748-6ab6a9204dc5
|
| 040 |
|
|
|a SNKBUCL
|b slo
|c SNKBUCL
|e AACR2
|
| 041 |
0 |
|
|a slo
|
| 044 |
|
|
|a xo
|c SK
|
| 080 |
|
|
|a 615.256
|2 1997
|
| 080 |
|
|
|a 615.35
|2 1997
|
| 100 |
1 |
|
|a Chalabala, Milan,
|d 1928-2003
|4 aut
|9 263426
|
| 245 |
1 |
0 |
|a Selektívny modulátor estrogénového receptora pre ženy po menopauze
|c M. Chalabala
|
| 300 |
|
|
|b Obr.
|
| 504 |
|
|
|a Bibliogr. odkazy
|
| 650 |
0 |
7 |
|a raloxifen
|2 snkbucl
|9 1415399
|
| 650 |
0 |
7 |
|a Evista (liek)
|2 snkbucl
|9 1415400
|
| 650 |
0 |
7 |
|a antiosteoporotiká
|2 snkbucl
|9 1415401
|
| 655 |
|
7 |
|a články z novín a časopisov
|2 snkbucl
|9 267496
|
| 773 |
0 |
|
|t Pharma journal
|g Roč. 10, č. 5 (2000), s. 107-108
|
| 850 |
|
|
|a Slovenská národná knižnica
|
| 852 |
|
|
|a Slovenská národná knižnica
|
| 954 |
|
|
|a odborná, vedecká literatúra pôvodná (slovenská)
|2 lita
|
| 958 |
|
|
|a article15
|
| 958 |
|
|
|a OND
|
| 958 |
|
|
|a MI
|
| 958 |
|
|
|a NB
|
| 958 |
|
|
|a EUIPO
|
| 992 |
|
|
|a RBX
|
| 999 |
|
|
|c 2867467
|d 2869397
|
